RAPT Therapeutics Inc - Medium Term Stock Analysis - Analysis | GetAGraph.com
Short-TermMedium-TermLong-TermSignals

RAPT Therapeutics Inc [RAPT]

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Last Updated 22 Jun 2026 @ 09:00 (Exchange is closed)
Last: $0 0.00%
2.86 (↓)
GaG Algo Score™
v1.0
Short
2.86 (↓)
Medium
4.71 (↓)
Long
4.58 (↓)
BUY
72.22%
return 0.55%
SELL
50.00%
return -0.23%

Stats

Today's Volume 0
Average Volume 0
Market Cap 959.26M
EPS $-0.0800 (Q1 | 2025-05-08)
ATR14 $0.416 (0.72%)
Possible DaySwing $57.80 - $58.22 (0.72%)

Support and Resistance Levels

Line

Pivot Data

Pivot Statistics
Metric Average Median Std Dev
Gain % 127.66% 94.53% 112.07%
Loss % -19.27% -19.27% 0.43%
Duration 41.4d 32d 22.2d
Total Pivots Found 6
Gain/Loss Legs 5 (3 Gain / 2 Loss)
Last Pivot Top @ $58.01 on 2026-03-06
Change since Last Pivot $0.00 (0.00%)
Next Pivot Prediction Last: $0.00
Predicted Next Type Bottom
Predicted Price (Avg) $46.83
Predicted Price (Median) $46.83
Predicted Price Range (~68%) $46.58 - $47.08
Change to Avg Target $46.83 (N/A)
Predicted Date (Avg) 2026-04-16
Predicted Date Range (~68%) 2026-03-25 - 2026-05-08
Basis Based on 2 historical losses (Avg: -19.27%, Median: -19.27%, StdDev of Abs: 0.43%) and duration (Avg: 41.4 days, StdDev: 22.2 days)
Note Ranges assume ~normal distribution & historical patterns repeat. Use with caution.

RAPT Therapeutics Inc flat yesterday.

RAPT Therapeutics Inc (RAPT) stock price finished at the same level as the previous day on Friday after the stock unchanged $0 (0.00%) from the previous session on extremely light volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 1.91% rise. With 0 shares traded, volume yesterday reached $0.00. This was 0 shares the same as the prior day. Compared to the 10-day average of 1.92M shares, volume was the same as the average.

RAPT Therapeutics Inc signals

The last upturn is pushing the stock into overbought territory (RSI above 70) with a current RSI of 75.67, which traditionally suggests the stock may be overvalued in the short term. The price is above both the short- and long-term averages, and the short-term average is above the long-term average, confirming an established up-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (40%), medium- (40%), and long-term (40%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

RAPT Therapeutics Inc Support & Resistance Levels

The stock is trading above the closest support level at $57.70. approximately $0.310 (0.53%) away. This suggests it is currently acting as a floor, consolidating near support.The sup dis das support -

RAPT Therapeutics Inc Evaluation

  • Short score: 2.86
  • Medium score: 4.71
  • Long score: 4.58